台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    85.5
  • 漲跌
    ▼0.3
  • 漲幅
    -0.35%
  • 成交量
    532
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-元富-吉利 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2603/1003/2003/3004/1204/22708090100110120130May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元富-吉利 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/16187.7000.0087.1011,8170.06%
2025/04/14286.2500.0085.1021,8330.11%
2025/04/11181.4000.0084.0011,8420.05%
2025/04/09280.65276.2076.5001,8440.00%
2025/04/08381.9700.0084.6031,8010.17%
2025/03/281102.001102.50100.5001,7520.00%
2025/03/2600.001105.00104.50-11,723-0.06%
2025/03/241107.0000.00105.5011,7140.06%
2025/03/2100.000106.00106.5001,7140.00%
2025/03/190105.5000.00104.5001,7180.00%
2025/03/170.2106.2500.00105.000.21,7140.01%
2025/03/140104.5000.00105.0001,7130.00%
2025/03/130.1105.0000.00103.500.11,7070.00%
2025/03/123107.5000.00107.0031,6950.18%
2025/03/074107.637107.57107.50-31,665-0.18%
2025/03/062110.501111.00111.0011,6470.06%
2025/03/050.3114.1700.00115.500.31,6450.02%
2025/03/0400.004112.00114.50-41,634-0.24%
2025/03/0300.001113.00112.50-11,620-0.06%
2025/02/2618117.0822116.30115.50-41,553-0.26%
2025/02/211112.5000.00113.0011,4120.07%
2025/02/2000.003111.00110.00-31,389-0.22%
2025/02/1700.000112.50112.5001,3970.00%
2025/02/111110.506.4109.25109.00-5.41,392-0.38%
2025/02/102.1118.294.2118.52118.50-2.11,337-0.15%
2025/02/0710119.251120.00120.5091,3510.67%
2025/02/062119.001117.50119.0011,3290.08%
2025/02/0500.003112.83113.00-31,194-0.25%
2025/02/0400.002102.50103.00-21,201-0.17%
2025/01/091.199.5600.0094.601.11,3410.08%
2025/01/0800.000.5102.50103.00-0.51,299-0.04%
2025/01/071100.002101.75101.50-11,275-0.08%
2025/01/0300.003.197.3598.30-3.11,240-0.25%
2024/12/3100.00190.1090.30-11,223-0.08%
2024/12/260.192.1000.0092.500.11,2250.00%
2024/12/2500.000.190.3091.00-0.11,214-0.01%
2024/12/240.188.4000.0087.400.11,2070.01%
2024/12/17186.5000.0086.7011,2230.08%
2024/12/160.188.0000.0086.300.11,2160.01%
2024/12/132.188.5100.0088.802.11,2090.17%
2024/12/121.190.6000.0090.201.11,1990.09%
2024/12/11192.1000.0090.6011,1930.08%
2024/12/100.192.2000.0092.100.11,1880.00%
2024/12/06294.10193.3093.3011,1800.08%
2024/12/05295.20295.4094.6001,1700.00%
2024/11/281.191.8300.0092.401.11,1100.09%
2024/11/220.194.4000.0093.800.11,0310.00%
2024/11/210.196.3000.0096.200.11,0210.01%
2024/11/180.197.9000.0096.500.11,0100.00%
2024/11/153.199.9014101.7199.90-11989-1.11%
2024/11/140.1102.503102.50101.50-3971-0.30%
2024/11/134108.0000.00106.5049460.42%
2024/11/1210.1104.4816100.69104.00-6916-0.65%
2024/11/1116104.2200.00103.50168821.81%
2024/11/071103.001105.50103.5008520.00%
2024/11/062102.5000.00102.5028260.24%
2024/11/0500.008100.00106.00-8782-1.02%
2024/11/0412101.633101.50100.0097581.19%
2024/11/012107.0000.00105.0027300.27%
2024/10/296101.0800.00100.5066040.99%
2024/10/2800.0013.1101.69102.00-13.1576-2.27%
2024/10/246100.002.399.4898.303.74940.75%
2024/10/23188.0000.0093.7014240.24%
2024/10/21286.7000.0086.7024180.48%
2024/10/17189.0000.0088.3014690.21%
2024/08/1600.00184.7084.60-1743-0.13%
2024/08/0900.00086.2085.4007830.00%
2024/08/06081.2000.0080.8007830.00%
2024/08/05083.1000.0083.0007640.00%
2024/07/190.396.7000.0094.200.37080.04%
2024/07/1800.00199.5099.40-1676-0.15%
2024/07/1100.003095.4395.20-30650-4.61%
2024/07/081100.0000.00100.5016550.15%
2024/07/02198.0000.0097.8016230.16%
2024/07/0100.004100.75101.00-4610-0.65%
2024/06/2600.00197.4097.60-1576-0.17%
2024/06/24393.57193.4093.2025890.34%
2024/06/14095.3000.0095.3006550.00%
2024/06/1300.00196.6096.90-1651-0.15%
2024/06/1200.00194.2094.80-1638-0.16%
2024/06/0600.00291.3091.10-2630-0.32%
2024/06/0300.00190.7090.70-1693-0.14%
2024/05/31191.00291.3090.60-1729-0.14%
2024/05/3000.00190.9090.30-1737-0.14%
2024/05/28192.4000.0092.3017600.13%
2024/05/1700.00198.6097.90-1872-0.11%
2024/05/16196.8000.0095.1018690.11%
2024/05/142.195.1300.0094.302.11,0430.20%
2024/04/25191.40190.8090.6001,4490.00%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章